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A De Novo Mutation (Gln2Stop) at the 5′ End of the
SRY Gene Leads to Sex Reversal with Partial Ovarian
Function
To the Editor:
In mammals, the development of the embryonic gonads
into either testes or ovaries determines gender. Sex re-
versal in XY females results from the failure of the in-
different gonad to develop into a testis. There are an
unknown number of genetic loci in the testis-determin-
ing pathway, but there is ample evidence that the Y-
chromosome gene that is essential for testicular devel-
opment is the testis-determining gene, SRY (Goodfellow
and Lovell-Badge 1993). Deletions of and inactivating
mutations of SRY are among the known causes of XY
sex reversal. Of XY females with pure gonadal dysge-
nesis, 10%–15% have been found to have mutations in
the SRY gene (Hawkins et al. 1992b; Affara et al. 1993;
Hawkins 1994). To date, 22 XY females with SRY mu-
tations have been reported, and all but two of the mu-
tations have been in the highly conserved high-mobil-
ity–group portion of the gene (i.e., the “HMG box”).
Of the two mutations not in the HMG box, one was a
deletion 5′ to the coding region of the gene (McElreavy
et al. 1992a), and the other was a point mutation 3′ to
the HMG box (Tajima et al. 1994). Patients with SRY
deletions or mutations are, in general, normal females
with complete gonadal dysgenesis. We describe a female
patient with premature ovarian failure, an XY karyo-
type, and a presumably inactivating mutation of her SRY
gene. We believe that this is the first reported case of an
XY female whose sex reversal is due to an SRY mutation
and in whom gonadal dysgenesis is incomplete. In ad-
dition, this patient’s SRY gene mutation is itself unusual,
in that it creates a stop in the second codon of the gene.
A third unusual feature of this case is that tubules sug-
gestive of early testicular development are seen in the
ovary.
The patient is a 28-year-old West Indian woman who
presented to one of us (L.S.), at the age of 28 years, with
the primary complaint of infertility. She reported me-
narche and normal breast development at age 13–14
years and had had regular monthly menses until age 17
years, when she electively began oral contraceptives,
which she continued until age 25 years. She reports that
irregular menses (every 28–45 d) resumed with the dis-
continuation of the oral-contraception and that for the
2 subsequent years she attempted to get pregnant. Prior
to our evaluation, she had been treated with clomiphene
citrate, for presumed anovulation. When she presented
to us, she was still having irregular menses. She appeared
normally feminized, and her physical exam, including
gynecological exam, was entirely normal, except for the
fact that she was 193 cm tall. Specifically, she was not
hirsute and had no stigmata of Turner syndrome. Breasts
and pubic hair were Tanner stage 4. The following hor-
mone levels were found: progesterone, 0.5 ng/ml; FSH,
44 mUI/ml; LH, 36 mUI/ml; prolactin, 12.8 ng/ml; tes-
tosterone, 0.25 ng/ml; and estradiol 2, 40 pg/ml. These
values all suggested nonfunctional ovaries. A chromo-
some analysis showed a 46,XY karyotype. At laparos-
copy, the gonads appeared to be white fibrous streaks
and were removed without difficulty. The excised tissue
was formalin fixed and routinely processed.
As noted, the patient’s history, physical exam, and
laboratory analysis were all suggestive of early ovarian
failure. Because of her oral-contraception regimen, we
cannot be sure about when her ovarian failure occurred;
however, the patient’s history of menses for 3 years after
the cessation of an oral-contraception regimen is con-
vincing. Standard G-banded chromosome analysis of pe-
ripheral lymphocytes showed a 46,XY karyotype in all
50 cells examined. Subsequently, fibroblasts cultured
from a skin biopsy gave the same result. Two-color in-
terphase FISH analysis of 100 nuclei by means of X and
Y centromere probes (obtained from Oncor) failed to
detect any cells with either two X chromosomes or with-
out a Y chromosome. The excised gonad from the right
side consisted entirely of fibroadipose tissue. The left
gonad contained a small amount of ovarian stromalike
tissue. No follicles were seen; however, a cluster of tu-
bular structures was present. One of the tubules was
ciliated, reminiscent of epididymis (fig. 1), and it was
concluded that the structures were suggestive of embry-
onic male type. Fibroblastlike cells cultured from both
gonadal-tissue samples also had a pure XY karyotype.
Because of the possibility of an SRY gene mutation,
the entire coding region of the SRY gene was amplified
from peripheral lymphocyte DNA, by means of primers
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Figure 1 H- and E-stained section of the ovary, showing a ciliated tubule reminiscent of epididymis.
Figure 2 Electropherogram showing mutant SRY sequence. Se-
quencing was done directly from the PCR product, by use of the
forward primer.
XES10 and XES11, as described elsewhere (Hawkins et
al. 1992a), and were cloned into a plasmid. Two inde-
pendent cloned PCR products showed the same CrT
transition in the second codon of the gene. This was the
only consistent deviation from the published sequence.
Subsequent direct sequencing of pooled PCR products
showed the same CrT transition (fig. 2). This CrT tran-
sition is predicted to create a stop codon (Gln2stop) at
the second codon of the gene. The SRY gene was am-
plified and sequenced from both ovaries, and the same
Cr T mutation was found to be present bilaterally. Thus,
there was no evidence of mosaicism for the mutation.
The patient’s father’s SRY gene was sequenced and was
shown to be entirely normal. In addition, paternity was
proved by the normal segregation of polymorphic PCR-
based markers (data not shown).
A stop mutation in the second codon of a gene is
unusual, and it is unclear how a eukaryotic ribosome
would respond to a stop placed immediately after the
initiating methionine. Either initiation would never pro-
ceed to elongation, resulting in complete absence of pro-
tein product, or a low level of readthrough would occur
with a reduced level of an otherwise normal protein. In
order to investigate whether this mutant stop completely
destroyed protein synthesis, hemagglutinin (HA)-tagged
constructs of both the normal and mutant SRY genes
were prepared. These constructs were then cloned into
a eukaryotic expression vector so that the HA-tagged
SRY gene was placed downstream from the cytomega-
lovirus promoter/enhancer. Normal and mutant con-
structs were transiently transfected into the BOSC 23
cell line by calcium phosphate coprecipitation, as de-
scribed by Pear et al. (1993). SRY-HA proteins from
lysates of transfected BOSC 23 cells were analyzed by
immunoblotting by means of methods described else-
where (Munsterberg et al. 1995). A representative result
is shown in figure 3; the higher-molecular-weight band
in the left-hand lane corresponds to the protein product
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Figure 3 Western blot analysis of transiently transfected HA-
tagged SRY constructs. The upper band in the left-hand lane arises
from the transfected SRY construct, the lower band, common to all
lanes, is due to nonspecific binding of the anti-HA antibody.
from a normal SRY gene, whereas no such band is de-
tectable with the mutant SRY allele (middle lane). The
constant band is due to nonspecific binding of the
anti–HA-tag antibody. Although only one representative
example is shown, this experiment was repeated a total
of four times, with identical results. We conclude from
this analysis that, if the mutant protein is expressed, it
must be at a level below the sensitivity of our system,
which we estimate to be ∼1%.
Among patients with sex reversal and SRY-gene mu-
tations, this woman is quite atypical, since she had nor-
mal menarche, normal secondary-sexual characteristics,
and 13 years of at least partial ovarian function after
the age of 25 years, when she discontinued an oral-
contraception regimen. A total of x22 SRY-gene mu-
tations have been reported by several authors (Hawkins
et al. 1992a; Jager et al. 1992; McElreavey et al. 1992a;
McElreavy et al. 1992b; Affara et al. 1993; Zeng et al.
1993; Iida et al. 1994; Poulat et al. 1994; Tajima et al.
1994; Schmitt-Ney et al. 1995). In all of the reported
cases, pure gonadal dysgenesis was present. This patient
has a single-base-change mutation of her SRY gene,
which is likely to have occurred either during spermat-
ogenesis or very early postzygotically. This mutation cre-
ates a stop codon immediately following the initiating
methionine and apparently inactivated her SRY gene. It
is unusual, since all other known mutations of the SRY
gene are either in the HMG-box region of the gene or
3′ to that region. It has been generally accepted that the
reason that most of the reported mutations in the SRY
gene are in the HMG box is that these are the mutations
that disrupt the function of the gene and that other mu-
tations are likely to be silent. However, premature ter-
mination upstream from the HMG box would also de-
stroy function and would not be predicted to be silent.
We considered the possibility that the unusual phenotype
(i.e., partially functional gonads) in this case might be
related to the unusual mutation. For instance, could a
low level of SRY protein lead to the survival of germ
cells? To this end, we sought to assess the possibility that
this mutation is “leaky.” Our results suggest that it is
not.
Another possibility is that the unusual mutation in
this patient has nothing to do with her unusual phe-
notype and that, with respect to the gonad, XY indi-
viduals with an SRY mutation are analogous to 45,X
(Turner syndrome) patients. In 45,X, the presence of
only one X chromosome is apparently not an absolute
barrier to ovarian function, since ∼5% of these girls will
have some ovarian function (Palmer and Reichmann
1979; Hall et al. 1982). It has been hypothesized that
this variation in the Turner-syndrome phenotype is due
to a variable rate of decay of the oocytes (Hall et al.
1982; Page et al. 1990). Only 22 patients with XY kar-
yotypes and SRY mutations have been described. If, as
in 45,X, there is significant variability in gonadal func-
tion, then 22 patients is not enough from which to draw
firm conclusions. As the number of such individuals in-
creases, it may become apparent that a small percentage
have partial ovarian function. This concept is supported
by the observation that, in mice, the presence of only
one X chromosome is associated with fertility and only
a mild reproductive disadvantage (Epstein 1986). In ad-
dition, a mouse with a heritable mutation in the testis-
determining gene has been described (Lovell-Badge and
Robertson 1990). XY mice with this mutation are fertile
females, although fertility is reduced, and their ovaries
fail early, a picture quite similar to that of the patient
whom we present.
In summary, we conclude that the patient whom we
present is sex reversed because of a point mutation in
her SRY gene. Further, we conclude that the presence of
a cytogenetically normal Y chromosome is not an ab-
solute barrier to ovarian function in humans. In addi-
tion, this and other reported patients prove that muta-
tions outside the HMG box of the SRY gene do occur
and should be looked for in the setting of sex reversal.
Although it is unlikely that many women with premature
ovarian failure will have a Y chromosome, it is still de-
sirable to karyotype all such women.
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Founder Effect, Seen in the British Population, of the
172 Peripherin/RDS Mutation—and Further
Refinement of Genetic Positioning
of the Peripherin/RDS Gene
To the Editor:
Peripherin/retinal degeneration slow (RDS) is a
membrane-associated glycoprotein found in the outer
segments of retinal rod and cone photoreceptor cells. It
is thought to play a role in membrane structural stabi-
lization, in conjunction with retinal outer segment
membrane protein 1 (ROM1).
Mutations in the RDS gene give rise to retinal degen-
erations with a wide phenotypic spectrum. The majority
of mutations result in macular dystrophies (reviewed in
Keen and Inglehearn 1996). Specific mutations in the
RDS gene may lead to a wide inter- and intrafamilial
variability of phenotype, as seen in one family with ret-
initis pigmentosa, pattern dystrophy, and fundus flavi-
maculatus, in three different members with a deletion at
codon 153/154. (Weleber et al. 1993)
Mutation analysis by heteroduplex and direct se-
quencing of PCR-amplified coding exons of the RDS
gene was performed in 300 British patients with dom-
inantly inherited macular dystrophies; 7.3% of this
group had peripherin/RDS mutations, segregating with
disease. One particular mutation accounted for 11 of
